Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-14 to 2024-02-05
Current total value of award: $30280
Description: ACQUISITION OF RECOMBINANT ANTIBODY AGAINST MOUSE ERBB2 (HER2) DOMAIN IV VIA A CUSTOM PROTEIN PRODUCTION SERVICES